About NanGenex Inc.

NanGenex is member of the DRGT Group. Headquartered in Swatar, Malta, Druggability Technologies is dedicated to the development and commercialization of high-value pharmaceutical products that deliver measurable and meaningful improvement in clinical efficacy. This mission is enabled through the deployment of DRGT’s Super-API Technology that delivers substantial improvement in pharmacokinetics and bioavailability resulting in high-value, proprietary products.

One of its subsidiaries, NanGenex Inc, is the technology company that develops and advances to the clinic specific high value compounds selected by the Group or from Bio-Pharma partners. The company is based in Budapest and was established in 2006 to develop the continuous flow based Super-API Technology and the related full scale, intelligent and integrated, GMP compliant instrument line.